Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bridgewater

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 9, 2020
Cholangiocarcinoma miscoding in hepatobiliary centresShaun Selvadurai, Kulbir Mann, Sanjena Mithra, et al.
Critical Reviews in Oncology/Hematology|November 25, 2010
Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerJunji Furuse, Takuji Okusaka, John Bridgewater, et al.
Tumori|May 24, 2014
Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United KingdomMatthew T Huggett, Helen Passant, Chris Hurt, et al.
British Journal of Cancer|February 19, 2016
Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN studyTal Grenader, Stephen Nash, Richard Adams, et al.
Endoscopy|May 1, 2015
Primary malignant melanoma of the esophagusGabriel Wallis, Vinay Sehgal, Aiman Haider, et al.
Anti-Cancer Drugs|March 3, 2017
Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN studyGeorgina Wood, Tal Grenader, Stephen Nash, et al.
Cancer|February 1, 2007
Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the USSamuel Aballéa, Jeremy V M Chancellor, Maria Raikou, et al.
Cancers|February 24, 2024
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid BiopsiesUmair Mahmood, Elisya Muhamad Faizul, Sarah Howlett, et al.
Cancers|December 2, 2020
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) ExperienceNalinie Joharatnam-Hogan, William Wilson, Kai Keen Shiu, et al.
Cancer Treatment Reviews|January 28, 2020
Current standards and future perspectives in adjuvant treatment for biliary tract cancersAngela Lamarca, Julien Edeline, Mairéad G McNamara, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 9, 2020
Cholangiocarcinoma miscoding in hepatobiliary centresShaun Selvadurai, Kulbir Mann, Sanjena Mithra, et al.
Critical Reviews in Oncology/Hematology|November 25, 2010
Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerJunji Furuse, Takuji Okusaka, John Bridgewater, et al.
Tumori|May 24, 2014
Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United KingdomMatthew T Huggett, Helen Passant, Chris Hurt, et al.
British Journal of Cancer|February 19, 2016
Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN studyTal Grenader, Stephen Nash, Richard Adams, et al.
Endoscopy|May 1, 2015
Primary malignant melanoma of the esophagusGabriel Wallis, Vinay Sehgal, Aiman Haider, et al.
Anti-Cancer Drugs|March 3, 2017
Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN studyGeorgina Wood, Tal Grenader, Stephen Nash, et al.
Cancer|February 1, 2007
Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the USSamuel Aballéa, Jeremy V M Chancellor, Maria Raikou, et al.
Cancers|February 24, 2024
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid BiopsiesUmair Mahmood, Elisya Muhamad Faizul, Sarah Howlett, et al.
Cancers|December 2, 2020
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) ExperienceNalinie Joharatnam-Hogan, William Wilson, Kai Keen Shiu, et al.
Cancer Treatment Reviews|January 28, 2020
Current standards and future perspectives in adjuvant treatment for biliary tract cancersAngela Lamarca, Julien Edeline, Mairéad G McNamara, et al.
Pageof 13